TwinStrand Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 38
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $16.3M
Latest Deal Amount
  • Investors
  • 8

TwinStrand Biosciences General Information

Description

Developer of a next-generation DNA sequencing therapy designed to detect ultra-rare variants of DNA molecules that are invisible by other sequencing approaches. The company's technique uses specialized adapters to uniquely tag both strands of individual DNA duplexes in a population, sequence and using proprietary software, read both strands of individual DNA molecules enabling researchers to get a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology

TwinStrand Biosciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TwinStrand Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 30-Dec-2019 $16.3M 000.00 Completed Generating Revenue
3. Grant 01-Jan-2019 00.00 00.00 Completed Generating Revenue
2. Grant 01-Jan-2018 $2.3M $6.1M Completed Generating Revenue
1. Seed Round 13-Sep-2017 $6.1M $6.1M 000.00 Completed Generating Revenue
To view TwinStrand Biosciences’s complete valuation and funding history, request access »

TwinStrand Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a next-generation DNA sequencing therapy designed to detect ultra-rare variants of DNA molecules that are i
Biotechnology
38 As of 2020
000.00
00000000000 000.00

0000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
0000000000000
Seattle, WA
00 As of 0000
000.00
000000&0 000.00

000000

rure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteu
0000000000000
Providence, RI
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TwinStrand Biosciences Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stratos Genomics Formerly VC-backed Seattle, WA 00 000.00 000000&0 000.00
000000 Venture Capital-Backed Providence, RI 00 0000 000000000 - 0000
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
00000000000 Corporate Backed or Acquired Bothell, WA 000000&0
00000000 0000000 0 Formerly VC-backed Castel Maggiore, Italy 000 000.00 000000 - 000
You’re viewing 5 of 34 competitors. Get the full list »

TwinStrand Biosciences Executive Team (7)

Name Title Board Seat Contact Info
Elena Cant Chief Operating Officer
Jeffry Grainger JD Chief Legal Officer
Jesse Salk Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Dionne Gordon Financial Controller
You’re viewing 4 of 7 executive team members. Get the full list »

TwinStrand Biosciences Board Members (11)

Name Representing Role Since
Chad Waite Jr. The W Fund Chairman 000 0000
Gary Gilliland MD Self Board Member 000 0000
Jesse Salk Ph.D TwinStrand Biosciences Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
Stephen Dow Self Board Member 000 0000
Terry Myerson TwinStrand Biosciences Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

TwinStrand Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TwinStrand Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Madrona Venture Group Venture Capital Minority 000 0000 000000 0
Ridgeback Capital Other Minority 000 0000 000000 0
Sahsen Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »